Division of Rheumatology, Department of Pediatrics, Children’s Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Susan Manzi
Autoimmunity Institute and Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, Pennsylvania, USA
Sawalha, A. H., & Manzi, S. (2020). Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus. European Journal of Rheumatology, 7(2), S117-S120. https://doi.org/10.5152/eurjrheum.2020.20055
Systemic lupus erythematosus is a chronic remitting-relapsing autoimmune disease that affects multiple organ systems. In this article we discuss aspects in the management of lupus patients that are particularly relevant during the current SARS-CoV-2 pandemic. We speculate that lupus patients might be more susceptible for a more severe COVID-19 disease course and emphasize the importance of maintaining remission in lupus patients. We discuss the critical role hydroxychloroquine plays in the management of lupus patients and suggest considering the psychosocial implications of the current pandemic on lupus care.
Cite this article as: Sawalha AH, Manzi S. Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus. Eur J Rheumatol 2020; 7(Suppl 2): S117-20.
Copyright (c) 2020 European Journal of Rheumatology
Affiliations
Amr H. Sawalha
Division of Rheumatology, Department of Pediatrics, Children’s Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Susan Manzi
Autoimmunity Institute and Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, Pennsylvania, USA
Cite this Article
Sawalha, A. H., & Manzi, S. (2020). Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus. European Journal of Rheumatology, 7(2), S117-S120. https://doi.org/10.5152/eurjrheum.2020.20055